JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 28.6 HKD -1.04% Market Closed
Market Cap: 91.2B HKD
Have any thoughts about
JD Health International Inc?
Write Note

JD Health International Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JD Health International Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
JD Health International Inc
HKEX:6618
EPS (Diluted)
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
58%
CAGR 10-Years
N/A
Vipshop Holdings Ltd
NYSE:VIPS
EPS (Diluted)
ÂĄ72
CAGR 3-Years
19%
CAGR 5-Years
37%
CAGR 10-Years
38%
Alibaba Group Holding Ltd
NYSE:BABA
EPS (Diluted)
ÂĄ4
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
12%
Pinduoduo Inc
NASDAQ:PDD
EPS (Diluted)
ÂĄ16
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Meituan
HKEX:3690
EPS (Diluted)
ÂĄ3
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
JD.Com Inc
HKEX:9618
EPS (Diluted)
ÂĄ11
CAGR 3-Years
11%
CAGR 5-Years
56%
CAGR 10-Years
N/A
No Stocks Found

JD Health International Inc
Glance View

Market Cap
90.9B HKD
Industry
Retail

JD Health International Inc. is not just another player in the rapidly evolving health and wellness landscape; it stands out as a pioneering force driven by technology and innovation. Established in 2015 as a subsidiary of JD.com, one of China's largest e-commerce platforms, JD Health is leveraging its parent company's robust logistics network and cutting-edge technology to reshape healthcare access in China. The company focuses on providing a seamless online healthcare experience, offering a diverse range of services that include online pharmacy sales, health consultations, and prescription management. With growing consumer demand for digital health solutions, JD Health is capitalizing on the shift toward telemedicine and remote healthcare services, positioning itself as a leader in this promising market. For investors, JD Health International Inc. represents a compelling opportunity rooted in strong growth prospects and market leadership. As digital health continues to gain traction, the company has demonstrated impressive revenue growth, propelled by its extensive user base and innovative service offerings. JD Health’s commitment to leveraging advanced technologies like artificial intelligence and big data analytics not only enhances operational efficiency but also improves customer satisfaction and outcomes. Coupled with a solid financial backing from JD.com's established marketplace and logistics capabilities, JD Health is strategically poised to expand its footprint in both urban and rural areas, ultimately aiming to bridge the healthcare accessibility gap in China. As the company navigates the dynamic healthcare environment, its growth trajectory suggests a sustainable business model with substantial long-term value.

Intrinsic Value
34.59 HKD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is JD Health International Inc's EPS (Diluted)?
EPS (Diluted)
0.7 CNY

Based on the financial report for Dec 31, 2023, JD Health International Inc's EPS (Diluted) amounts to 0.7 CNY.

What is JD Health International Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
58%

Over the last year, the EPS (Diluted) growth was 467%.

Back to Top